Overview

Olmesartan Medoxomil Versus Losartan in Patients With Hypertension

Status:
Completed
Trial end date:
2003-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the efficacy and safety of oral administration of olmesartan medoxomil compared to losartan in subjects with mild to moderate hypertension.
Phase:
Phase 3
Details
Lead Sponsor:
Daiichi Sankyo Inc.
Daiichi Sankyo, Inc.
Collaborator:
Daiichi Sankyo Taiwan Ltd.
Treatments:
Angiotensin Receptor Antagonists
Losartan
Olmesartan
Olmesartan Medoxomil